Contrarian Corpus

358 documents showing 241–300

Elliott Management 2016-11-21

Marathon Petroleum Corporation MPC

Marathon's integrated structure hides $14–19bn of value; dropping all MLP-qualifying assets to MPLX and spinning Speedway, refining, and midstream into three standalone companies would lift shares 60–80%+.

N4 V1 C1
Elliott Management 2016-11-01

Marathon Petroleum Corporation MPC

Marathon is priced like a merchant refiner despite a 69% stable-earnings mix; dropping assets to MPLX and spinning Speedway, RefiningCo, and MidstreamCo unlocks $14-19bn (~60-80%+ upside).

N4 V4 C4
Elliott Management 2016-10-05

Samsung Electronics Co., Ltd. 005930.KS

Samsung Electronics trades at a 30-70% discount to peers on EV/EBITDA, P/E and P/B

N4 V4 C3
Starboard Value 2016-09-12

Perrigo Company plc PRGO

Perrigo lost half its value after rejecting Mylan's $205 bid; divesting Rx and Tysabri royalty, fixing BCH margins, and restoring credibility can re-rate the stock to consumer-staples peers.

N4 V3 C3
Sandell 2016-08-22

Bob Evans Farms, Inc. BOBE

Bob Evans trades at $37 while its packaged-foods segment alone is worth $1.2-1.6bn; spinning off Restaurants leaves a pure-play BEF Foods parent worth $57-79 per share.

N4 V3 C2
Pershing Square 2016-07-20

Herbalife HLF

FTC complaint confirms Herbalife operates as a pyramid scheme

N4 V3 C3
Marcato 2016-06-13

Buffalo Wild Wings BWLD

Buffalo Wild Wings should reverse course on low-return franchisee buy-ins, refranchise to 90% by 2020, recapitalize, and fix incentives — unlocking ~180% upside to ~$402.

N4 V4 C4
Pershing Square 2016-04-26

Multiple (portfolio-level LP update: MDLZ, APD, ZTS, QSR, CP, HHC, VRX, PAH, FNMA/FMCC, NOMD, HLF)

Mondelez margin gap to peers (13% vs 17-26%) implies +600-700bps of optimized EBIT upside

N3 V3 C3
Pershing Square 2016-04-26

Multiple (Pershing Square portfolio: MDLZ, APD, ZTS, QSR, CP, HHC, VRX, NOMD, HLF-short)

Mondelez EBIT margin of 13.1% is far below peers (Kraft Heinz 26.5%, Hershey 20.0%) and well short of 3G playbook results

N3 V3 C2
Muddy Waters 2016-04-21

Ströer SE & Co. KGaA SAX

Ströer's digital-transformation narrative is hollow: organic growth is 10x overstated, EBITDA and FCF are inflated, and insider self-dealing rivals Chinese fraud cases — short.

N4 V2 C1
Marcato 2016-04-06

Epiq Systems, Inc. EPIQ

Epiq's board has insulated management through chronic guidance misses, a failed Iris acquisition and governance entrenchment; electing Villere's alternate slate is the unique opportunity to unlock value.

N4 V3 C3
Engaged Capital 2016-02-18

Outerwall Inc. OUTR

Outerwall's cash-rich Redbox/Coinstar business trades at a 3x EBITDA capital-allocation discount; halting buybacks for a large dividend and running a sale process unlocks 150%+ upside.

N4 V3 C3
Elliott Management 2016-02-04

Bank of East Asia, Limited 0023.HK

BEA delivered 2.7% annualised return since 1997 vs 12.8% for family-run HK bank peers

N4 V4 C4
Pershing Square 2016-01-28

Pershing Square portfolio (multi-holding LP update: MDLZ, VRX, APD, ZTS, CP, QSR, HHC, PAH, FNMA/FMCC, HLF short)

2015 was -20.5% but portfolio trades at substantial discount to intrinsic value

N4 V3 C3
SpringOwl 2016-01-13

Viacom VIAB

Viacom's absent chair Redstone and overpaid CEO Dauman have driven a lost decade; replacing leadership, cutting $400M SG&A and launching OTT unlocks up to 135% upside to $95.90.

N4 V2 C2
Starboard Value 2016-01-11

Macy's Inc. M

Macy's owns $21bn of real estate — more than its entire enterprise value; spinning iconic and mall properties into two JVs unlocks ~$70/share, ~88% upside.

N4 V3 C3
Starboard Value 2016-01-06

Yahoo! Inc. YHOO

Three years of failed turnaround have collapsed Yahoo's Core Business; Starboard demands a competitive sale process and leadership change, or it will launch an election contest.

N4 V2 C2
SpringOwl 2015-12-01

Yahoo! Inc. YHOO

Yahoo's Core is mismanaged but fixable — replace Mayer with an operator CEO, cut headcount two-thirds, bring Liberty in as a partner, and shares triple from $35 to $113.

N4 V3 C3
Starboard Value 2015-11-19

Yahoo! Inc. YHOO

Yahoo should scrap the Aabaco spin-off and instead sell the Core Business outright, returning cash to shareholders and keeping Alibaba and Yahoo Japan stakes in the remaining entity.

N4 V2 C2
Greenlight Capital 2015-11-16

CONSOL Energy CNX

Market prices CONSOL as a dying coal miner, but its Marcellus/Utica shale gas acreage plus disciplined management make it worth $35.81/share versus $7.40 today.

N5 V3 C3
Elliott Management 2015-11-16

American Capital Ltd. ACAS

ACAS trades at 71% of NAV vs 115% peer median — chronic discount since 2008

N4 V4 C4
Pershing Square 2015-10-30

Valeant Pharmaceuticals International VRX

Citron's 'next Enron' channel-stuffing claim is verifiably false; Philidor accounting is conservative

N4 V3 C2
Trian Partners 2015-10-05

General Electric GE

GE has quietly pivoted to a focused industrial post-GE Capital exit; executing 16% margins, prudent leverage and ~$100bn of buybacks gets the stock to $40-$45 by end-2017.

N4 V3 C2
Starboard Value 2015-09-30

Advance Auto Parts AAP

AAP trails O'Reilly and AutoZone by 800-900bps in EBITDA margins; closing the gap plus Worldpac monetization, buybacks, and multiple rerating drives AAP from $171 to over $350.

N4 V3 C3
Starboard Value 2015-08-10

Yahoo! Inc. YHOO

Yahoo's Core Business is collapsing because of $550M of self-inflicted cost bloat; cutting costs and replacing the Microsoft search deal can restore profitability without touching Alibaba.

N4 V2 C3
Pershing Square 2015-08-01

Herbalife Ltd. HLF

Herbalife pays multi-level royalties on unlimited downlines, violating China's pyramid-sales laws

N5 V3 C2
Oasis Management 2015-07-01

Japanese listed companies (market-level)

Japan's twin Corporate Governance and Stewardship Codes, paired with strong Companies Act shareholder rights, will drive an ROE revolution making Japan one of the best long-term equity markets.

N3 V3 C2
Pershing Square 2015-05-04

Valeant Pharmaceuticals International VRX

Platform companies are undervalued because P/E ignores value from future acquisitions

N5 V4 C4
Pershing Square 2015-05-01

Valeant Pharmaceuticals International VRX

Traditional P/E ignores Valeant's 'Platform Value' from disciplined M&A capital allocation

N4 V3 C3
Engaged Capital 2015-04-22

Rovi Corporation ROVI

Rovi's entrenched board destroyed a decade of shareholder value while promising 'double-digit growth next year' every year; Engaged's nominees Lockwood and Rau bring operating credibility the incumbents lack.

N4 V3 C3
Trian Partners 2015-04-22

E. I. du Pont de Nemours and Company DD

DuPont is a chronically underperforming conglomerate; electing Trian's four nominees forces structural review, cost cuts, and governance reform to unlock $120+/share by 2017 — a 21% IRR.

N5 V4 C4
Trian Partners 2015-04-21

E.I. du Pont de Nemours and Company DD

DuPont is bottom-quartile under Ellen Kullman; electing Trian's four nominees unlocks $120/share by 2017 by cutting $2-4bn of excess corporate costs and ending 'crony' compensation.

N5 V4 C4
Trian Partners 2015-04-21

E.I. du Pont de Nemours and Company (DuPont) DD

DuPont is a chronically underperforming conglomerate bloated with $2-4bn of excess costs; putting Trian on the board unlocks a $120+/share, 21% IRR path by 2017.

N5 V3 C3
Trian Partners 2015-04-17

E.I. du Pont de Nemours and Company (DuPont) DD

DuPont is a chronic underperformer under CEO Kullman; electing Nelson Peltz and three nominees unlocks $2-4bn of excess costs and drives DuPont stock to $120 by 2017 (21% IRR).

N4 V3 C3
Trian Partners 2015-04-13

E.I. du Pont de Nemours and Company DD

DuPont is a bloated conglomerate hiding $2-4bn of excess corporate costs and crony compensation; Trian's board nominees can unlock $120/share by 2017 — a 21% IRR.

N4 V3 C3
Greenlight Capital 2015-04-07

AerCap Holdings AER

AerCap, the largest independent aircraft lessor, trades at 8.5x earnings; the equity should rerate as the credit markets already have post-ILFC deal, supported by low-teens ROE and ~10% EPS CAGR.

N4 V3 C3
Trian Partners 2015-04-01

H.J. Heinz Company HNZ

Retrospective of Trian's 2006 Heinz campaign: a 13D white paper and proxy-won board seats drove brand reinvestment and cost discipline, delivering 178% TSR versus 40% for the S&P 500.

N3 V3 C3
Land & Buildings 2015-03-17

MGM Resorts International MGM

MGM's US real estate is buried inside a 10x-EBITDA C-corp; a REIT conversion plus lodging-C-corp spin and MGM China dividend can lift NAV from $33 to $55 per share.

N4 V2 C1
Marcato 2015-03-01

The Bank of New York Mellon BK

BNY Mellon has squandered the 2007 Mellon merger under CEO Hassell; cutting ~10,000 excess FTEs and installing new leadership closes the State Street gap for 114% upside.

N4 V4 C4
Pershing Square 2015-02-26

Herbalife HLF

Former distributors lost $5K-$45K each chasing promised income that never materialized

N4 V1 C1
Trian Partners 2015-02-17

E.I. du Pont de Nemours and Company (DuPont) DD

DuPont is an underperforming conglomerate burdened with $2-4bn of excess costs; elect Trian's four nominees to drive separation, cost cuts, and board accountability.

N5 V3 C3
Sandell 2015-02-01

Brookdale Senior Living Inc. BKD

BKD trades at a wide discount because its owned real estate is buried inside an OpCo; a tax-free PropCo/OpCo REIT spin plus governance overhaul unlocks ~$49/share.

N4 V3 C3
Pershing Square 2015-01-29

Multiple (Pershing Square portfolio - annual update)

2014 net returns of 40.4% vs S&P 500's 13.7%, driven by Allergan (+19.1%), CP (+7.0%), and Herbalife short (+6.1%)

N3 V3 C3
Pershing Square 2015-01-29

Multiple (PSH portfolio: AGN, HLF short, APD, CP, QSR/BKW, PAH, ZTS, HHC, FNMA/FMCC)

Concentrated activist strategy delivered 40.4% net returns in 2014 vs. 13.7% for S&P 500

N3 V3 C3
Sandell 2014-11-01

TransCanada Corp TRP

TransCanada is an undervalued conglomerate; spinning off Energy and doing an all-in dropdown into TCP — Spectra-style — re-rates the parts to roughly $75/share.

N4 V4 C4
Marcato 2014-11-01

Dillard's, Inc. DDS

Dillard's trades at 6.2x EBITDA despite owning ~50mm sq. ft. of real estate; separating into OpCo/PropCo as peers have done implies ~$193/share vs. $109.

N3 V3 C3
Corvex 2014-10-14

Crown Castle International Corp. CCI

Crown Castle is a U.S. tower REIT 'betwixt and between' — raising the 2015 dividend to $4.00 (80% AFFO payout) re-rates the stock to a 4.0% yield, unlocking 27% near-term and 60%+ upside in 15 months.

N4 V3 C3
Starboard Value 2014-09-11

Darden Restaurants, Inc. DRI

Darden's brands and real estate are worth $67-$86/share vs. $48 today — replace the entire board to execute the Brinker playbook: operational turnaround, real-estate separation, SRG spin-off.

N5 V3 C3
Starboard Value 2014-09-11

Darden Restaurants, Inc. DRI

Darden underperformed direct peers by ~300% over 5 years under current Board

N5 V3 C4
Starboard Value 2014-09-01

Darden Restaurants DRI

Starboard's REIT math inflates multiples by ~4x turns through flawed peer selection and LTM vs. forward mismatch

N3 V3 C2
Starboard Value 2014-05-22

Darden Restaurants, Inc. DRI

Darden's Board destroyed value by selling Red Lobster for ~1x EBITDA against shareholder will; replacing 12 directors unlocks a real estate spin, cost-cut turnaround, and peer-catchup upside.

N4 V2 C2
Spruce Point Capital 2014-05-20

iRobot Corp IRBT

IRBT is a narrow consumer-vacuum company riding a robotics bubble; aggressive accounting, insider selling and a decaying moat point to $20-$25, or 25-40% downside.

N4 V3 C3
Greenlight Capital 2014-05-05

athenahealth ATHN

athenahealth is the poster child of the cloud 'bubble basket' — strip Morgan Stanley's fantasy margin and revenue-per-doctor assumptions and the stock falls 80%+ toward a $50 adjusted DCF.

N5 V2 C2
Pershing Square 2014-05-05

Fannie Mae & Freddie Mac FNMA / FMCC

Reformed GSEs worth $23-$47/share vs $3.98 today — 6x to 12x upside

N4 V4 C3
Marcato 2014-04-22

Sotheby's BID

Sotheby's sits on $1bn+ of excess capital while insiders own 0.8%; Third Point's slate brings aligned ownership to drive capital return, cost discipline, and higher ROE.

N4 V3 C3
Pershing Square 2014-04-22

Allergan AGN

Valeant's Outsider-CEO model delivered 2,544% TSR (25x) in six years under Mike Pearson

N4 V3 C3
Third Point 2014-04-01

Sotheby's BID

Sotheby's Board has presided over a 42% EPS collapse despite global wealth tailwinds; electing Third Point's three nominees can restore owner perspective and more than double pro-forma EPS.

N4 V3 C3
Starboard Value 2014-03-31

Darden Restaurants, Inc. DRI

Darden is rushing a value-destructive Red Lobster spin-off; a Special Meeting can halt it and unlock $1-2B of real estate and operational upside instead.

N4 V3 C3
Starboard Value 2014-03-31

Darden Restaurants, Inc. DRI

Darden's rushed Red Lobster spin is the wrong deal at the wrong time — it traps ~$850M of real estate value and blocks a $1-2B REIT unlock; shareholders must call a Special Meeting to stop it.

N5 V3 C3
Trian Partners 2014-02-19

PepsiCo, Inc. PEP

PepsiCo has chronically underperformed because its 'Power of One' holding-company structure suffocates Frito-Lay and Pepsi; separate them into two focused companies and the combined value will re-rate materially higher.

N5 V3 C2